Davunetide vs PACAP-38

Head-to-head comparison of Davunetide (Activity-Dependent Neuroprotective Protein fragment NAP (NAPVSIPQ)) and PACAP-38 (Pituitary Adenylate Cyclase-Activating Polypeptide-38 (human PACAP-38)) — benefits, dosing, side effects, research data, and where to buy.

Research Score

PropertyDavunetidePACAP-38
CategoryCognitive EnhancementCognitive Enhancement
Full NameActivity-Dependent Neuroprotective Protein fragment NAP (NAPVSIPQ)Pituitary Adenylate Cyclase-Activating Polypeptide-38 (human PACAP-38)
Molecular Weight796.9 Da4534 Da
Half-Lifeshort; minutes to low hoursminutes
Amino Acids838 aa
Typical Dose1-10 mg/day research range10-100 µg preclinical range
RouteIntranasalIntranasal
Purity≥98%≥98%
Studies Count40650
Research StatusClinical/Pre-clinicalPre-clinical

Davunetide Benefits

  • neuroprotection
  • microtubule support
  • attention support
  • memory preservation

PACAP-38 Benefits

  • synaptic plasticity
  • BDNF upregulation
  • neuroprotection
  • memory consolidation

Davunetide Dosing

intranasal research dosing|1-10 mg per dose in trials/preclinical work|once or twice daily

PACAP-38 Dosing

0.1-1 nmol ICV in rodents|10-100 µg intranasal in preclinical studies|single-dose or short repeated protocols

Davunetide Side Effects

  • nasal irritation
  • headache
  • limited efficacy in late-stage trials

PACAP-38 Side Effects

  • headache-like effects
  • flushing
  • hypotension

Research Overview

Davunetide

Preclinical work showed davunetide can protect neurons, preserve synaptic structure, and improve performance in memory tasks. Human trials largely focused on neurodegenerative disease outcomes rather than stand-alone nootropic use, but the literature supports CNS activity.

PACAP-38

PACAP-38 is one of the most studied endogenous neuropeptides for protecting neurons from ischemic and excitotoxic damage. Preclinical literature also links it to hippocampal plasticity and learning-related signaling, including increased BDNF expression.

Ready to buy?

Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.

Common Stacking Partners

Davunetide stacks with:

gpenoopeptdesmopressin

PACAP-38 stacks with:

citicolinealpha-gpcomega-3
octapeptideADNPneuroprotectionneurotrophicbdnfsynaptic-plasticity